Table of Contents

Articles

• You have access

  The in Vivo Human Metabolism of Tibolone

  R. M. E. Vos, S. F. M. Krebbers, C. H. J. Verhoeven and L. P. C. Delbressine

  Drug Metabolism and Disposition February 2002, 30 (2) 106-112; DOI: https://doi.org/10.1124/dmd.30.2.106
• You have access

  Reductive Metabolism ofp,p′-DDT ando,p′-DDT by Rat Liver Cytochrome P450

  Shigeyuki Kitamura, Yuri Shimizu, Yuko Shiraga, Mayumi Yoshida, Kazumi Sugihara and Shigeru Ohta

  Drug Metabolism and Disposition February 2002, 30 (2) 113-118; DOI: https://doi.org/10.1124/dmd.30.2.113
• You have access

  Cloning, Sequencing, and Tissue-Dependent Expression of Flavin-Containing Monooxygenase (FMO) 1 and FMO3 in the Dog

  Virginie Lattard, Christiane Longin-Sauvageon, Joel Lachuer, Paul Delatour and Etienne Benoit

  Drug Metabolism and Disposition February 2002, 30 (2) 119-128; DOI: https://doi.org/10.1124/dmd.30.2.119
• You have access

  UDP Glucuronosyltransferase mRNA Levels in Human Liver Disease

  Mario Congiu, Maurice L. Mashford, John L. Slavin and Paul V. Desmond

  Drug Metabolism and Disposition February 2002, 30 (2) 129-134; DOI: https://doi.org/10.1124/dmd.30.2.129
• You have access

  The Effect of Bergamottin on Diazepam Plasma Levels and P450 Enzymes in Beagle Dogs

  Jasminder Sahi, Eric L. Reyner, Jonathan N. Bauman, Kristina Gueneva-Boucheva, James E. Burleigh and V. Hayden Thomas

  Drug Metabolism and Disposition February 2002, 30 (2) 135-140; DOI: https://doi.org/10.1124/dmd.30.2.135
• You have access

  Middle-Age Alterations in the Sexually Dimorphic Plasma Growth Hormone Profiles: Involvement of Growth Hormone-Releasing Factor and Effects on Cytochrome P450 Expression

  Ravindra N. Dhir, Wojciech Dworakowski and Bernard H. Shapiro

  Drug Metabolism and Disposition February 2002, 30 (2) 141-147; DOI: https://doi.org/10.1124/dmd.30.2.141
• You have access

  Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism

  T. Gul Altuntas and Evan D. Kharasch

  Drug Metabolism and Disposition February 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148
• You have access

  Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells

  Yui Yamamoto, Hiroshi Yamazaki, Tomoko Ikeda, Terumi Watanabe, Haruo Iwabuchi, Miki Nakajima and Tsuyoshi Yokoi

  Drug Metabolism and Disposition February 2002, 30 (2) 155-160; DOI: https://doi.org/10.1124/dmd.30.2.155
• You have access

  Conjugation of Desmethylnaproxen in the Rat—A Novel Acyl Glucuronide-Sulfate Diconjugate as a Major Biliary Metabolite

  R. Jaggi, R. S. Addison, A. R. King, B. D. Suthers and R. G. Dickinson

  Drug Metabolism and Disposition February 2002, 30 (2) 161-166; DOI: https://doi.org/10.1124/dmd.30.2.161
• You have access

  Pharmacokinetics and Biliary Excretion of Osaterone Acetate, a New Steroidal Antiandrogen, in Dogs

  Kouichi Minato, Naoyuki Koizumi, Seijirou Honma, Kunio Tsukamoto and Satoshi Iwamura

  Drug Metabolism and Disposition February 2002, 30 (2) 167-172; DOI: https://doi.org/10.1124/dmd.30.2.167
• You have access

  Brain Pharmacokinetics of a Nonpeptidic Corticotropin-Releasing Factor Receptor Antagonist

  Caroline Keller, Armin Bruelisauer, Michel Lemaire and Albert Enz

  Drug Metabolism and Disposition February 2002, 30 (2) 173-176; DOI: https://doi.org/10.1124/dmd.30.2.173
• You have access

  The Influence of l-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition

  Andrew A. Shaw, Stephen D. Hall, Michael R. Franklin and Raymond E. Galinsky

  Drug Metabolism and Disposition February 2002, 30 (2) 177-182; DOI: https://doi.org/10.1124/dmd.30.2.177
• You have access

  Kinetics of Cisplatin Binding to Cellular DNA and Modulations by Thiol-Blocking Agents and Thiol Drugs

  Peter D. Sadowitz, Bradley A. Hubbard, James C. Dabrowiak, Jerry Goodisman, Kirk A. Tacka, Mehmet K. Aktas, Mary J. Cunningham, Ronald L. Dubowy and Abdul-Kader Souid

  Drug Metabolism and Disposition February 2002, 30 (2) 183-190; DOI: https://doi.org/10.1124/dmd.30.2.183
• You have access

  Investigation of the Mechanism of Enhancement of Central Nervous System Delivery of 2′-β-Fluoro-2′,3′-Dideoxyinosine Via a Blood-Brain Barrier Adenosine Deaminase-Activated Prodrug

  Mark D. Johnson, Jian Chen and Bradley D. Anderson

  Drug Metabolism and Disposition February 2002, 30 (2) 191-198; DOI: https://doi.org/10.1124/dmd.30.2.191
• You have access

  Characterization of Catechol Glucuronidation in Rat Liver

  Laurence Antonio, Joël-Paul Grillasca, Jyrki Taskinen, Eivor Elovaara, Brian Burchell, Marie-Helene Piet, Brian Ethell, Mohamed Ouzzine, Sylvie Fournel-Gigleux and Jacques Magdalou

  Drug Metabolism and Disposition February 2002, 30 (2) 199-207; DOI: https://doi.org/10.1124/dmd.30.2.199
• You have access

  Retinoic Acids Repress Constitutive Active Receptor-Mediated Induction by 1,4-bis[2-(3,5-Dichloropyridyloxy)]benzene of theCyp2b10 Gene in Mouse Primary Hepatocytes

  Satoru Kakizaki, Sohrab Karami and Masahiko Negishi

  Drug Metabolism and Disposition February 2002, 30 (2) 208-211; DOI: https://doi.org/10.1124/dmd.30.2.208
• You have access

  Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels

  A. L. Slitt, N. J. Cherrington, D. P. Hartley, T. M. Leazer and C. D. Klaassen

  Drug Metabolism and Disposition February 2002, 30 (2) 212-219; DOI: https://doi.org/10.1124/dmd.30.2.212
• You have access

  Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates

  Daisuke Sugiyama, Hiroyuki Kusuhara, Yoshihisa Shitara, Takaaki Abe and Yuichi Sugiyama

  Drug Metabolism and Disposition February 2002, 30 (2) 220-223; DOI: https://doi.org/10.1124/dmd.30.2.220